Amy Berrington de González is a scientist and Professor of Clinical Epidemiology at the Institute of Cancer Research in London, England.

[1] Berrington de González was on the faculty at the University of Oxford and then Johns Hopkins Bloomberg School of Public Health before moving to the Radiation Epidemiology Branch at the National Cancer Institute (NCI) in 2008.

Berrington de González serves on two radiation risk committees for the National Academy of Science and previously served on the UK Health Protection Agency's Advisory Group on Ionising Radiation, and the UK Breast Screening Programme's Advisory Group.

[3] The overarching goal of Prof Berrington's research is to quantify the potential cancer risks from this important source of radiation exposure in order to provide information for public health and clinical purposes.

The studies vary across the dose-spectrum from low-dose diagnostic and screening procedures to high-dose radiotherapy, with distinct opportunities and challenges in each area.